IPG Photonics announced a binding offer to acquire Lumibird Medical for €300 million, with an additional earnout of up to €50 million based on performance. This acquisition will expand IPG's Advanced Solutions portfolio in medical lasers, particularly in ophthalmology and urology, adding about $1 billion in addressable market. The deal is expected to enhance IPG's gross margin, EBITDA, and adjusted EPS, creating a larger platform for growth and innovation. The transaction is anticipated to close in Q4 2026, funded by cash on hand, pending regulatory approvals and consultation processes.
Constellation Software Inc. announced it will hold a conference call and live webcast on August 12, 2026, at 8:00 a.m. ET to discuss its second quarter results. The company will release its quarterly earnings after the Toronto Stock Exchange closes o...
Morgan Stanley increased its price target for United Airlines to $190, suggesting nearly 60% upside from the current price of $118.81. The airline's stock has surged 235% since October 2023, driven by a strong rebound in international travel and rais...
Citizens Financial Group reported a strong Q2 performance with earnings per share of $1.30, surpassing estimates by 4% and marking a 41% increase year-over-year. The bank also posted revenue of $2.28 billion, beating expectations and continuing a fou...
Yara International ASA is set to release its Q2 2026 earnings on July 17, with analysts expecting an EPS of $1.19 and revenue of $5.14 billion. The fertilizer industry faces challenges from rising raw material costs and potential demand decline due t...
Cycurion received a Nasdaq delisting notice due to its stock price falling below the $1 minimum for 31 consecutive days. The company is appealing the decision, which allows its shares to keep trading on Nasdaq during the review. Cycurion is focused o...
